Ifn-α and il-10 induce the differentiation of human type 1 t regulatory cells1

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5530-5539

  Levings, M K ^a   Sangregorio, R ^a   Galbiati, F ^a   Squadrone, S ^a   De Waal Malefyt, R ^a   Roncarolo, M G ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ALPHA INTERFERON; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0035339884     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5530     Document Type: Article

References (64)

1. Functional diversity of helper T lymphocytes
2. + T cell responses: The alternative approaches
3. The interplay between the duration of TCR and cytokine signaling determines T cell polarization
4. + T cells
5. Cytokines induce the development of functionally heterogeneous T helper cell subsets
6. The Th1/Th2 paradigm
7. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
8. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
9. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells
10. + T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-γ and granulocyte/ macrophagecolony-stimulating factor but not IL-4
11. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
12. Activated self-MHCreactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells
13. + T cells
14. + suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD rrdce
15. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
16. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo
17. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: Implications in designing antigen-presenting cell-based tumor vaccines
18. Anergy and cytokinemediated suppression as distinct superantigen-induced tolerance mechanisms in vivo
19. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
20. + T cell down-regulation in human intestinal mucosa: Evidence for intestinal tolerance to luminal bacterial antigens
21. + T cell lines
22. + cytotoxic T lymphocytes
23. + T cells, analyzed at the single-cell level
24. IL-4 Inhibits the production of TNF-α and IL-12 by STAT6-dependent and -independent mechanisms
25. Heterodimerization of the α and β chains of the interleukin-3 (IL-3) receptor is necessary and sufficient for IL-3-induced mitogenesis
26. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production
27. + T cell alloantigenspecific hyporesponsiveness by IL-10 and TGF-β
28. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype
29. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production
30. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
31. Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood
32. Immunologic properties of cord blood
33. Interleukin-10
34. Antiproliferative action of intefferon-α requires components of T-cell-receptor signalling
35. Regulatory T cells in autoimmmunity
36. Interleukin-12 primes human CD4 and CD8 T cells clones for high production of both interferon-γ and interleukin-10
37. IL-12 induced human T cells secreting IL-10 with IFN-γ
38. Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-α
39. Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle
40. + T cells
41. Type 1 interferons keep activated T cells alive
42. Intefferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pira-I genes in human T cells
43. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
44. + Th1/Th2 cells
45. TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression
46. + T cells
47. Interferon-α inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins
48. + T cells
49. The role of Star4 in species-specific regulation of Th cell development by type I IFNs
50. A receptor for interleukin 10 is related to interferon receptors
51. Signaling and transcription in T helper development
52. IL-10 induces the tyrosine phosphorylation of tyk2 and Jakl and the differential assembly of STAT1 α and STAT3 complexes in human T cells and monocytes
53. Functional regions of the mouse interleukin-10 receptor cytoplasmic domain
54. Jaks and STATs: Biological implications
55. Reciprocal control of T helper cell and dendritic cell differentiation
56. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
57. Natural interferon α/β-producing cells link innate and adaptive immunity
58. Type I IFN modulates innate and specific antiviral immunity
59. Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients
60. Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferonβ-1b treatment
61. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-α (TNF-α)- and IL-10-secreting blood cells that is corrected by intefferon-β (IFN-β) treatment
62. The role of different subsets of T regulatory cells in controlling autoimmunity
63. Regulatory T cells: Key controllers of immunologic selftolerance
64. + immunoregulatory T cells that control autoimmune diabetes